[1]
|
Anissipour, A.K., et al. (2014) Behavior of Scoliosis during Growth in Children with Osteogenesis Imperfecta. The Journal of Bone & Joint Surgery, 96, 237-243. https://doi.org/10.2106/JBJS.L.01596
|
[2]
|
Karbowski, A., Schwit-alle, M. and Eckardt, A. (1999) [Scoliosis in Patients with Osteogenesis Imperfecta: A Federal Nation-Wide Cross-Sectional Study]. Zeitschrift für Orthopädie und Unfallchirurgie, 137, 219-222.
https://doi.org/10.1055/s-2008-1037397
|
[3]
|
Martin, E. and Shapiro, J.R. (2007) Osteogenesis Imperfecta: Epide-miology and Pathophysiology. Current Osteoporosis Reports, 5, 91-97. https://doi.org/10.1007/s11914-007-0023-z
|
[4]
|
Beighton, P. and Versfeld, G.A. (1985) On the Paradoxically High Relative Prevalence of Osteogenesis Imperfecta Type III in the Black Population of South Africa. Clinical Genetics, 27, 398-401.
https://doi.org/10.1111/j.1399-0004.1985.tb02282.x
|
[5]
|
Viljoen, D. and Beighton, P. (1987) Osteogenesis Imper-fecta Type III: An Ancient Mutation in Africa? American Journal of Medical Genetics, 227, 907-912. https://doi.org/10.1002/ajmg.1320270417
|
[6]
|
Takagi, M., Sato, S., Hara, K., Tani, C., Miyazaki, O., Nishimura, G. and Hasegawa, T. (2013) A Recurrent Mutation in the 5’-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V. American Journal of Medical Genetics Part A, 161, 1980-198255. https://doi.org/10.1002/ajmg.a.36025
|
[7]
|
Hoyer-Kuhn, H., Netzer, C. and Semler, O. (2015) Osteogenesis Imper-fecta: Pathophysiology and Treatment. Wiener Medizinische Wochenschrift, 165, 278-284. https://doi.org/10.1007/s10354-015-0361-x
|
[8]
|
Hollister, D.W. (1987) Molecular Basis of Osteogenesis Imper-fecta. In: Current Problems in Dermatology, Vol. 17, Karger International, Basel, 76-94. https://doi.org/10.1159/000413476
|
[9]
|
Bianchi, L., Gagliardi, A., Maruelli, S., et al. (2015) Altered Cytoskeletal Organization Characterized Lethal but Not Surviving Brtl+/- Mice: Insight on Phenotypic Variability in Osteogenesis Im-perfecta. Human Molecular Genetics, 24, 6118-6133. https://doi.org/10.1093/hmg/ddv328
|
[10]
|
Zaripova, A.R. and Khusainova, R.I. (2020) Modern Classification and Molecular-Genetic Aspects of Osteogenesis Imperfecta. Vavi-lovskii Zhurnal Genetiki i Selektsii, 24, 219-227. https://doi.org/10.18699/VJ20.614
|
[11]
|
Jovanovic, M., Guter-man-Ram, G. and Marini, J.C. (2022) Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Clas-sical and Rare OI Types. Endocrine Reviews, 43, 61-90. https://doi.org/10.1210/endrev/bnab017
|
[12]
|
Byers, P.H. (2002) Killing the Messenger: New Insights Intononsense-Mediated mRNA Decay. Journal of Clinical Investigation, 109, 3-6. https://doi.org/10.1172/JCI0214841
|
[13]
|
Glorieux, F.H. (2008) Osteogenesis Imperfecta. Best Practice & Research Clinical Rheumatology, 22, 85-100.
https://doi.org/10.1016/j.berh.2007.12.012
|
[14]
|
Cheung, M.S., Arponen, H., Roughley, P., Azouz, M.E., Glorieux, F.H., Waltimo-Siren, J. and Rauch, F. (2011) Cranial Base Abnormalities Inosteogenesis Imperfecta: Phenotypic and Genotypic Determinants. Journal of Bone and Mineral Research, 26, 405-413. https://doi.org/10.1002/jbmr.220
|
[15]
|
Rossi, V., Lee, B. and Marom, R. (2019) Osteogenesis Imperfecta: Ad-vancements in Genetics and Treatment. Current Opinion in Pediatrics, 31, 708-715. https://doi.org/10.1097/MOP.0000000000000813
|
[16]
|
Hanagata, N. (2016) IFITM5 Mutations and Osteogenesis Imperfecta. Journal of Bone and Mineral Metabolism, 34, 123-131. https://doi.org/10.1007/s00774-015-0667-1
|
[17]
|
Cho, T.J., Lee, K.E., Lee, S.K., Song, S.J., Kim, K.J., Jeon, D., Lee, G., Kim, H.N., Lee, H.R., Eom, H.H., Lee, Z.H., Kim, O.H., Park, W.Y., Park, S.S., Ikegawa, S., Yoo, W.J., Choi, I.H. and Kim, J.W. (2012) A Single Recurrent Mutation in the 5’-UTR of IFITM5 Causes Osteogenesis Imperfecta Type V. The American Journal of Human Genetics, 91, 343-334. https://doi.org/10.1016/j.ajhg.2012.06.005
|
[18]
|
Semler, O., Garbes, L., Keupp, K., Swan, D., Zimmermann, K., Becker, J., Iden, S., Wirth, B., Eysel, P., Koerber, F., Schoenau, E., Bohlander, S.K., Wollnik, B. and Netzer, C. (2012) A Mutation in the 5’-UTR of IFITM5 Creates an In-Frame Start Codon and Causes Autosomal-Dominant Osteogenesis Imperfecta Type V with Hyperplastic Callus. The American Journal of Human Genetics, 91, 349-335. https://doi.org/10.1016/j.ajhg.2012.06.011
|
[19]
|
Campeau, P.M. and Lee, B.H. (2013) Phenotyic Variability of Osteogenesis Imperfect Type V Caused by an IFITM5 Mutation. Journal of Bone and Mineral Research, 28, 1523-1530. https://doi.org/10.1002/jbmr.1891
|
[20]
|
Balasubramanian, M., Parker, M.J., Dalton, A., Giunta, C., Lindert, U., Peres, L.C., Wagner, B.E., Arundel, P., Offiah, A. and Bishop, N.J. (2013) Geno-type-Phenotype Study in Type V Osteogenesis Imperfecta. Clinical Dysmorphology, 22, 93-101. https://doi.org/10.1097/MCD.0b013e32836032f0
|
[21]
|
Zhang, Z., Li, M., He, J.W., Fu, W.Z., Zhang, C.Q. and Zhang, Z.L. (2013) Phenotype and Genotype Analysis of Chinese Patients with Osteogenesis Imperfect Type V. PLOS ONE, 8, e7233756.
https://doi.org/10.1371/journal.pone.0072337
|
[22]
|
Grover, M., Campeau, P.M., Lietman, C.D., Lu, J.T., Gibbs, R.A., Schles-inger, A.E. and Lee, B.H. (2013) Osteogenesis Imperfecta Type without Features of Type V Caused by a Mutation in the IFITM5 Gene. Journal of Bone and Mineral Research, 28, 2333-2337. https://doi.org/10.1002/jbmr.1983
|
[23]
|
Kim, O.H., Jin, D.K., Kosaki, K., Kim, J.W., Cho, S.Y., Yoo, W.J., Choi, I.H., Nishimura, G., Ikegawa, S. and Cho, T.J. (2013) Osteogenesis Imperfect Type V: Clinical and Radiographic Mani-festations in Mutation Confirmed Patients. American Journal of Medical Genetics Part A, 161, 1972-197958. https://doi.org/10.1002/ajmg.a.36024
|
[24]
|
Etich, J., Leßmeier, L., Rehberg, M., Sill, H., Zaucke, F., Netzer, C. and Semler, O. (2020) Osteogenesis Imperfecta-Pathophysiology and Therapeutic Options. Molecular and Cellular Pediat-rics, 7, Article No. 9.
https://doi.org/10.1186/s40348-020-00101-9
|
[25]
|
Forlino, A. and Marini, J.C. (2016) Osteogenesis Imperfecta. The Lancet, 387, 1657-1671.
https://doi.org/10.1016/S0140-6736(15)00728-X
|
[26]
|
Kang, H., Aryal, A.C.S. and Marini, J.C. (2017) Osteogen-esis Imperfecta: New Genesreveal Novel Mechanisms in Bone Dysplasia. Translational Research, 181, 27-48. https://doi.org/10.1016/j.trsl.2016.11.005
|
[27]
|
Morello, R., Bertin, T.K., Chen, Y., et al. (2006) CRTAP Is Re-quired for Prolyl 3-Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta. Cell, 127, 291-304. https://doi.org/10.1016/j.cell.2006.08.039
|
[28]
|
Barnes, A.M., Chang, W., Morello, R., et al. (2006) Deficiency of Cartilage-Associated Protein in Recessive Lethal Osteogenesis Imperfecta. The New England Journal of Medicine, 355, 2757-2764.
https://doi.org/10.1056/NEJMoa063804
|
[29]
|
Cabral, W.A., Chang, W., Barnes, A.M., et al. (2007) Prolyl 3-Hydroxylase 1 Deficiency Causes a Recessive Metabolic Bone Disorder Resembling Lethal/Severe Osteogenesis Im-perfecta. Nature Genetics, 39, 359-365.
https://doi.org/10.1038/ng1968
|
[30]
|
Cabral, W.A., Perdivara, I., Weis, M., Terajima, M., Blissett, A.R., Chang, W., et al. (2014) Abnormal Type I Collagen Post-Translational Modification and Crosslinking ina Cyclophilin B KO Mouse Model of Recessive Osteogenesis Imperfecta. PLOS Genetics, 10, e1004465. https://doi.org/10.1371/journal.pgen.1004465
|
[31]
|
Seyedhassani, S.M., Hashemi-Gorji, F., Yavari, M., Harazi, F. and Yassaee, V.R. (2016) Novel FKBP10 Mutation in a Patient with Osteogenesis Imperfecta Type XI. Fetal and Pedi-atric Pathology, 35, 353-358.
https://doi.org/10.1080/15513815.2016.1191567
|
[32]
|
Lietman, C.D., Rajagopal, A., Homan, E.P., Munivez, E., Jiang, M.M., Bertin, T.K., Chen, Y., Hicks, J., Weis, M., Eyre, D., Lee, B. and Krakow, D. (2014) Connective Tissue Alterations in Fkbp10-/- Mice. Human Molecular Genetics, 23, 4822-4831. https://doi.org/10.1093/hmg/ddu197
|
[33]
|
Patterson, C.E., Abrams, W.R., Wolter, N.E., Rosenbloom, J. and Davis, E.C. (2005) Developmental Regulation and Coordinate Reexpression of FKBP65 with Extracellular Matrix Proteins after Lung Injury Suggesta Specialized Function for this Endoplasmic Reticulum Immunophilin. Cell Stress and Chaperones, 10, 285-295.
|
[34]
|
Steinlein, O.K., Aichinger, E., Trucks, H. and Sander, T. (2011) Mutations in FKBP10 Can Cause a Severe form Ofisolated Osteogenesis Imperfecta. BMC Medical Genetics, 12, Article No. 152.
https://doi.org/10.1186/1471-2350-12-152
|
[35]
|
Moravej, H., Karamifar, H., Karamizadeh, Z., Amirhakimi, G., Atashi, S. and Nasirabadi, S. (2015) Bruck Syndrome—A Rare Syndrome of Bone Fragility and Joint Contracture and Novel Homozygous FKBP10 Mutation. Endokrynologia Polska, 66, 170-174. https://doi.org/10.5603/EP.2015.0024
|
[36]
|
Barnes, A.M., Duncan, G., Weis, M., Paton, W., Cabral, W.A., Mertz, E.L., Makareeva, E., Gambello, M.J., Lacbawan, F.L., Leikin, S., Fertala, A., Eyre, D.R., Bale, S.J. and Marini, J.C. (2013) Kuskokwim Syndrome, a Recessive Congenital Contracture Disorder, Extends the Phenotype of FKBP10 Muta-tions. Human Mutation, 34, 1279-1288.
https://doi.org/10.1002/humu.22362
|
[37]
|
Capitani, M. and Sallese, M. (2009) The KDEL Receptor: New Functions for an Old Protein. FEBS Letters, 583, 3863-3871. https://doi.org/10.1016/j.febslet.2009.10.053
|
[38]
|
Efthymiou, S., Herman, I., Rahman, F., Anwar, N., Maroofian, R., Yip, J., Mitani, T., Calame, D.G., Hunter, J.V., Sutton, V.R., Yilmaz Gulec, E., Duan, R., Fatih, J.M., Marafi, D., Pehlivan, D., Jhangiani, S.N., Gibbs, R.A., Posey, J.E., SYNAPS Study Group, Maqbool, S., Lupski, J.R. and Houlden, H. (2021) Two Novel Bi-Allelic KDELR2 Missense Variants Causeos-teogenesis Imperfecta with Neurodevelopmental Features. American Journal of Medical Genetics Part A, 185, 2241-2249. https://doi.org/10.1002/ajmg.a.62221
|
[39]
|
van Dijk, F.S., Semler, O., Etich, J., Köhler, A., Jimenez-Estrada, J.A., Bravenboer, N., Claeys, L., Riesebos, E., Gegic, S., Piersma, S.R., Jimenez, C.R., Waisfisz, Q., Flores, C.L., Nevado, J., Harsevoort, A.J., Janus, G.J.M., Franken, A.A.M., van der Sar, A.M., Meijers-Heijboer, H., Heath, K.E., Lapunzina, P., Nikkels, P.G.J., Santen, G.W.E., Nüchel, J., Plomann, M., Wagener, R., Rehberg, M., Hoyer-Kuhn, H., Eekhoff, E.M.W., Pals, G., Mörgelin, M., Newstead, S., Wilson, B.T., Ruiz-Perez, V.L., Maugeri, A., Netzer, C., Zaucke, F. and Micha, D. (2020) Interaction between KDELR2 and HSP47 as a Key Determinant in Osteogenesis Imperfecta Caused by Bi-allelic Variants in KDELR2. The American Journal of Human Genetics, 107, 989-999. https://doi.org/10.1016/j.ajhg.2020.09.009
|
[40]
|
Martínez-Glez, V., Valencia, M., Caparrós-Martín, J.A., Aglan, M., Temtamy, S., Tenorio, J., et al. (2012) Identification of a Mutation Causing Deficient BMP1/mTLD Proteolytic Activity in Autosomal Recessive Osteogenesis Imperfecta. Human Mutation, 33, 343-350. https://doi.org/10.1002/humu.21647
|
[41]
|
Murakami, T., Saito, A., Hino, S., et al. (2009) Signalling Mediated by the Endoplasmic Reticulum Stress Transducer OASIS Is Involved in Bone Formation. Nature Cell Biology, 11, 1205-1211. https://doi.org/10.1038/ncb1963
|
[42]
|
Faqeih, E., Shaheen, R. and Alkuraya, F.S. (2013) WNT1 Muta-tion with Recessive Osteogenesis Imperfecta and Profound Neurological Phenotype. Journal of Medical Genetics, 50, 491-492.
https://doi.org/10.1136/jmedgenet-2013-101750
|
[43]
|
Laine, C.M., Joeng, K.S., Campeau, P.M., et al. (2013) WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta. The New England Journal of Medicine, 368, 1809-1916. https://doi.org/10.1056/NEJMoa1215458
|
[44]
|
Pyott, S.M., Tran, T.T., Leistritz, D.F., et al. (2013) WNT1 Mutations in Families Affected by Moderately Severe and Progressive recessive Osteogenesis Imperfecta. Amer-ican Journal of Human Genetics, 92, 590-597.
https://doi.org/10.1016/j.ajhg.2013.02.009
|
[45]
|
Keupp, K., Beleggia, F., Kayserili, H., et al. (2013) Mutations in WNT1 Cause Different Forms of Bone Fragility. American Journal of Human Genetics, 92, 565-574. https://doi.org/10.1016/j.ajhg.2013.02.010
|
[46]
|
Gewartowska, O., Aranaz-Novaliches, G., Krawczyk, P.S., Mroczek, S., Kusio-Kobiałka, M., Tarkowski, B., Spoutil, F., Benada, O., Kofroňová, O., Szwedziak, P., Cysewski, D., Gruchota, J., Szpila, M., Chlebowski, A., Sedlacek, R., Prochazka, J. and Dziembowski, A. (2021) Cytoplasmic Poly-adenylation by TENT5A Is Required for Proper Bone Formation. Cell Reports, 35, Article ID: 109015. https://doi.org/10.1016/j.celrep.2021.109015
|
[47]
|
Hojo, H. and Ohba, S. (2022) Sp7 Action in the Skeleton: Its Mode of Action, Functions and Relevance to Skeletal Diseases. International Journal of Molecular Sciences, 23, Article 5647. https://doi.org/10.3390/ijms23105647
|
[48]
|
Wang, J.S., Tokavanich, N. and Wein, M.N. (2023) SP7: From Bone Development to Skeletal Disease. Current Osteoporosis Reports, 21, 241-252. https://doi.org/10.1007/s11914-023-00778-7
|
[49]
|
Lapunzina, P., Aglan, M., Temtamy, S., Caparros-Martin, J.A., Valencia, M., Leton, R., et al. (2010) Identification of a Frameshift Mutation in Osterix in a Patientwith Recessive Oste-ogenesis Imperfecta. American Journal of Human Genetics, 87, 110-114. https://doi.org/10.1016/j.ajhg.2010.05.016
|
[50]
|
Al-Jallad, H., Palomo, T., Roughley, P., Glorieux, F.H., McKee, M.D., Moffatt, P. and Rauch, F. (2015) The Effect of SERPINF1 In-Frame Mutations in Osteogenesis Imperfecta Type VI. Bone, 76, 115-120.
https://doi.org/10.1016/j.bone.2015.04.008
|
[51]
|
Ghosh, D.K., Udupa, P., Shrikondawar, A.N., Bhavani, G.S., Shah, H., Ranjan, A. and Girisha, K.M. (2023) Mutant MESD Links Cellular Stress to Type I Collagen Aggregation in Osteogenesis Imperfecta Type XX. Matrix Biology, 115, 81-106. https://doi.org/10.1016/j.matbio.2022.12.001
|
[52]
|
Moosa, S., Yamamoto, G.L., Garbes, L., Keupp, K., Bele-za-Meireles, A., Moreno, C.A., Valadares, E.R., de Sousa, S.B., Maia, S., Saraiva, J., Honjo, R.S., Kim, C.A., Cabral de Menezes, H., Lausch, E., Lorini, P.V., Jr Lamounier, A., Carniero, T.C.B., Giunta, C., Rohrbach, M., Janner, M., Semler, O., Beleggia, F., Li, Y., Yigit, G., Reintjes, N., Altmüller, J., Nürnberg, P., Cavalcanti, D.P., Zabel, B., Warman, M.L., Bertola, D.R., Wollnik, B. and Netzer, C. (2019) Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imper-fecta. American Journal of Human Genetics, 105, 836-843. https://doi.org/10.1016/j.ajhg.2019.08.008
|
[53]
|
Dubail, J., Brunelle, P., Baujat, G., Huber, C., Doyard, M., Michot, C., Chavassieux, P., Khairouni, A., Topouchian, V., Monnot, S., Koumakis, E. and Cormier-Daire, V. (2020) Homozygous Loss-of-Function Mutations in CCDC134 Are Responsi-ble for a Severe Form of Osteognesis Imperfecta. Journal of Bone and Mineral Research, 35, 1470-1480.
https://doi.org/10.1002/jbmr.4011
|
[54]
|
Stürznickel, J., Jähn-Rickert, K., Zustin, J., et al. (2021) Compound Heter-ozygous Frameshift Mutations in MESD Cause a Lethal Syndrome Suggestive of Osteogenesis Imperfecta Type XX. Journal of Bone and Mineral Research, 36, 1077-1087. https://doi.org/10.1002/jbmr.4277
|